发明名称 PROPARGYLAMINO INDAN DERIVATIVES AND PROPARGYLAMINO TETRALIN DERIVATIVES AS BRAIN-SELECTIVE MAO INHIBITORS
摘要 The subject invention provides derivatives of propargylamino indan (PAI) and propargylamino tetralin that selectively inhibit monoamine oxidase (MAO) in the brain, having the structure:, wherein R1 is OC (O) R9 and R2 is H, wherein R9 i s branched or unbranched C1 to C6 alkyl, aryl, or aralkyl, or R1 is OC (O) R4 and R2 is OC (O) R4, wherein R4 is branched or unbranched C1 to C6 alkyl, aryl, aralkyl or NR5R6, wherein R5 and R6 are each independently H, C1 to C8 alkyl, C6 to C12 aryl, C6 to C12 aralkyl or C6 to C12 cycloalkyl, each optionally substituted; wherein R3 is H or C1 to C6 alkyl; wherein n is 0 or 1; and wherein m is 1 or 2, or a pharmaceutically acceptable salt thereof. Additionally, the subject invention provides methods of treating neurological disorders using these compounds, uses of these compounds for the manufacture of medicaments for treating neurological disorders and processes for synthesis of these compounds.
申请公布号 WO03072055(A2) 申请公布日期 2003.09.04
申请号 WO2003US05871 申请日期 2003.02.27
申请人 TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICALS, INC. 发明人 BLAUGRUND, ERAN;HERZIG, YAACOV;STERLING, JEFFREY
分类号 A61P15/10;A61K31/216;A61K31/22;A61P21/00;A61P25/00;A61P25/08;A61P25/16;A61P25/24;A61P25/28;A61P43/00;C07C215/64;C07C219/26;C07C271/44;C07D265/12 主分类号 A61P15/10
代理机构 代理人
主权项
地址